Trial intelligence / Profile preview

Angiotensin 1-7 for COVID-19 Pneumonia

NCT04605887Phase 2Unknown

Sponsor
Rambam Health Care Campus
Start
Jan 2021
Primary completion
Nov 2023
Countries
1
01

Overview

A Phase 2 trial of angiotensin-(1-7) in coronavirus disease 2019 (COVID-19), sponsored by Rambam Health Care Campus. Status: unknown.

02

Drugs

angiotensin-(1-7)
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on NCT04605887.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04605887.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call